1. Mortality rates in incident ESRD patients figure 9
Mortality rates in incident ESRD patients figure 9.1 adjusted 1st year death rates adjusted for age, gender, race, & primary diagnosis

2. Mortality rates in prevalent ESRD patients figure 9
Mortality rates in prevalent ESRD patients figure 9.2 adjusted 1st year death rates are adjusted for age, gender, race, & primary diagnosis

3. Death rates in period prevalent dialysis patients age 65+, by primary diagnosis figure 9.3, 2000, unadjusted

4. All-cause mortality in the general Medicare & dialysis populations, patients age 65+, 1999, unadjusted figure 9.4, period prevalent general Medicare & period prevalent dialysis pts
Patients by cardiovascular disease

5. Geographic variations in all-cause mortality rates in patients age 65+, by patient population figure 9.5, period prevalent general Medicare & period prevalent dialysis pts
General Medicare
Deaths per 1,000
patient years
58.2+ (59.2)
56.5 to <58.2
55.0 to <56.5
52.9 to <55.0
below 52.9 (51.1)

6. Geographic variations in all-cause mortality rates in patients age 65+, by patient population figure 9.5, period prevalent general Medicare & period prevalent dialysis pts
Dialysis
Deaths per 1,000
patient years
377+ (390)
365 to <377
353 to <365
339 to <353
below 339 (324)

7. All-cause mortality in the general Medicare & dialysis populations, patients age 65+, by diabetic status figure 9.6, period prevalent patients, 1999, unadjusted

8. All-cause mortality in the general Medicare & dialysis populations, patients age 65+, by gender figure 9.7, period prevalent patients, 1999, unadjusted

9. All-cause mortality in the general Medicare & dialysis populations, patients age 65+, by age: 0-44 & figure 9.8, period prevalent patients, 1999, unadjusted

10. All-cause mortality in the general Medicare & dialysis populations, patients age 65+, by age: & 75+ figure 9.8, period prevalent patients, 1999, unadjusted (cont.)

11. All-cause mortality in the general Medicare & dialysis populations, patients age 65+, all & white figure 9.9, period prevalent patients, 1999, unadjusted

12. All-cause mortality in the general Medicare & dialysis populations, patients age 65+, Native Am. & Asian figure 9.9, period prevalent patients, 1999, unadjusted
Cardiovascular
disease
No cardiovascular

13. All-cause mortality in the general Medicare & dialysis populations, patients age 65+, black figure 9.9, period prevalent patients, 1999, unadjusted
450
350
250
150 50
Cardiovascular
disease
No cardiovascular
Non-CKD CKD Dialysis
Non-CKD CKD Dialysis

14. All-cause mortality in the general Medicare & dialysis populations, patients age 65+, Hispanic figure 9.9, period prevalent patients, 1999, unadjusted
450
350
250
150 50
Cardiovascular
disease
No cardiovascular

15. Mortality rates, by age, race/ethnicity, & gender figure 9
Mortality rates, by age, race/ethnicity, & gender figure 9.10, adjusted for diabetic status, eGFR, & BMI

16. Mortality rates, by age, race/ethnicity, & gender figure 9
Mortality rates, by age, race/ethnicity, & gender figure 9.10, adjusted for diabetic status, eGFR, & BMI (cont.)

17. Relative risk of mortality (with 95% confidence interval) table 9
Relative risk of mortality (with 95% confidence interval) table 9.a, incidence dialysis patients, combined

18. Mortality rates, by estimated glomerular filtration rate & race figure 9.11, adjusted for age, diabetic status, & BMI
Deaths per 1,000 patient years

19. Mortality rates, by estimated glomerular filtration rate, ethnicity & gender figure 9.11, adjusted for age, diabetic status & BMI (cont.)
Deaths per 1,000 patient years

20. Mortality rates, by body mass index & race figure 9
Mortality rates, by body mass index & race figure 9.12, adjusted for age, diabetic status & eGFR
Deaths per 1,000 patient years

21. Mortality rates, by body mass index, ethnicity & gender figure 9
Mortality rates, by body mass index, ethnicity & gender figure 9.12, adjusted for age, diabetic status & eGFR
Deaths per 1,000 patient years

22. Mortality rates in diabetics, by age, race, & gender figure 9
Mortality rates in diabetics, by age, race, & gender figure 9.13, adjusted for eGFR & BMI
Deaths per 1,000 patient years
Age group

23. Mortality rates in diabetics, by age, ethnicity, & gender figure 9
Mortality rates in diabetics, by age, ethnicity, & gender figure 9.13, adjusted for eGFR & BMI
Deaths per 1,000 patient years
Age group

24. Mortality rates in non-diabetics, by age, race & gender figure 9
Mortality rates in non-diabetics, by age, race & gender figure 9.13, adjusted for eGFR & BMI (cont.)
Non-diabetic
Deaths per 1,000 patient years
Age group

25. Mortality rates in non-diabetics, by age, ethnicity & gender figure 9
Mortality rates in non-diabetics, by age, ethnicity & gender figure 9.13, adjusted for eGFR & BMI (cont.)
Non-diabetic
Deaths per 1,000 patient years
Age group

26. Relative risk of all-cause mortality (with 95% confidence interval) by gender* table 9.b, incident hemodialysis patients, combined
*Survive the period 4-9 months post ESRD 1st date with factors
defined in the entry period or from the ME form, follow-up 1 yr

27. Relative risk of all-cause mortality (with 95% confidence interval) by race* table 9.c, incident hemodialysis patients, combined
*Survive the period 4-9 months post ESRD 1st date with factors
defined in the entry period or from the ME form, follow-up 1 yr

28. Relative risk of all-cause mortality (with 95% confidence interval) by diabetic status* table 9.d, incident hemodialysis patients, combined
*Survive the period 4-9 months post ESRD 1st date with factors
defined in the entry period or from the ME form, follow-up 1 yr

29. One-year mortality rates, by hemoglobin, gender, race, & diabetic status* figure 9.14, adjusted for age, ethnicity, BMI, & URR
*Survive the period 4-9 months post ESRD 1st date with factors
defined in the entry period or from the ME form, follow-up 1 yr

30. One-year mortality rates, by URR, gender, race, & diabetic status
One-year mortality rates, by URR, gender, race, & diabetic status* figure 9.15, adjusted for age, ethnicity, BMI, & hemoglobin
*Survive the period 4-9 months post ESRD 1st date with factors
defined in the entry period or from the ME form, follow-up 1 yr

31. Mortality rates, by urea reduction ratio, race/ethnicity, & body mass index: white figure 9.16, adjusted for age, gender, diabetic status, & hemoglobin

32. Survival curves by age & gender: IgA nephro
Survival curves by age & gender: IgA nephro./Berger’s, IgM nephropathy figure 9.17, incident dialysis patients, combined
Months of survival

33. Survival curves by age & gender: Goodpasture’s syndrome figure 9
Survival curves by age & gender: Goodpasture’s syndrome figure 9.18, incident dialysis patients, combined

34. Survival curves by age & gender: lupus erythematosus (SLE nephritis) figure 9.19, incident dialysis patients, combined

35. Survival curves by age & gender: other secondary GN/vasculitis figure 9.20, incident dialysis patients, combined

36. Survival curves by age & gender: scleroderma figure 9
Survival curves by age & gender: scleroderma figure 9.21, incident dialysis patients, combined

37. Survival curves by age & gender: Alport’s, other hereditary/familial disease figure 9.22, incident dialysis patients, combined

38. Survival curves by age & gender: Multiple myeloma & light chain nephropathy figure 9.23, incident dialysis pts, , adjusted for age, gender, & race

39. Survival curves, by age & gender: AIDS nephropathy figure 9
Survival curves, by age & gender: AIDS nephropathy figure 9.24, incident dialysis patients, combined, adjusted for age, gender, & race

40. Expected remaining lifetimes (years) of dialysis & transplant patients table 9.e, ESRD data: prevalent dialysis & transplant patients, 2000

41. Expected remaining lifetimes (years) of the general population table 9
Expected remaining lifetimes (years) of the general population table 9.e, 1999, from the National Vital Statistics Reports

42. Expected remaining lifetimes in patients with increasing morbidity, by age figure 9.25, chronic kidney disease & diabetes, prevalent dialysis patients, 2000

43. Expected remaining lifetimes in patients with increasing morbidity, by age figure 9.26, diabetes, chronic kidney disease, & chronic heart

44. Geographic variations in expected remaining lifetimes: age 0-19, dialysis figure 9.27, prevalent dialysis pts, 2000, by state, unadjusted
Years
20.5+ (21.3)
19.6 to <20.5
19.1 to <19.6
18.5 to <19.1
below 185 (175)

45. Geographic variations in expected remaining lifetimes: age 0-19, transplant figure 9.27, prevalent transplant pts, 2000, by state, unadjusted
Years
(53.6)
49.2 to <50.9
47.6 to <49.2
46.2 to <47.6
below 46.2 (43.7)

46. Geographic variations in expected remaining lifetimes: age 0-19, general Medicare figure 9.27, 2000, unadjusted
Years
57.8+ (60.6)
56.9 to <57.8
54.5 to <56.9
52.4 to <54.5
below 52.4 (49.7)

47. Geographic variations in expected remaining lifetimes: age 20-44, dialysis figure 9.27, prevalent dialysis patients, 2000, unadjusted
Years
12.0+ (12.5)
11.3 to <12.0
11.0 to <11.3
10.6 to <11.0
below 10.6 (9.7)

48. Geographic variations in expected remaining lifetimes: age 20-44, transplant figure 9.27, prevalent transplant patients, 2000, unadjusted
Years
35.2+ (37.5)
33.1 to <35.2
32.5 to <33.1
31.3 to <32.5
below 31.3 (29.2)

49. Geographic variations in expected remaining lifetimes: age 20-44, general Medicare figure 9.27, 2000, unadjusted
Years
41.7+ (43.6)
41.1 to <41.7
39.7 to <41.1
38.3 to <39.7
below 38.3 (36.6)

50. Geographic variations in expected remaining lifetimes: age 45-64, dialysis figure 9.27, prevalent dialysis patients, 2000, unadjusted
Years
6.0+ (6.3)
5.8 to <6.0
5.5 to <5.8
5.2 to <5.5
below 5.2 (4.8)

51. Geographic variations in expected remaining lifetimes: age 45-64, transplant figure 9.27, prevalent transplant patients, 2000, unadjusted
Years
19.6+ (21.3)
18.0 to <19.6
17.6 to <18.0
16.7 to <17.6
below 16.7 (15.2)

52. Geographic variations in expected remaining lifetimes: age 45-64, general Medicare figure 9.27, 2000, unadjusted
Years
25.3+ (26.3)
24.7 to <25.3
24.1 to <24.7
23.4 to <24.1
below 23.4 (22.8)

53. Geographic variations in expected remaining lifetimes: age 65+, dialysis figure 9.27, prevalent dialysis patients, 2000, unadjusted
Years
3.0+ (3.1)
2.9 to <3.0
2.8 to <2.9
2.7 to <2.8
below 2.7 (2.5)

54. Geographic variations in expected remaining lifetimes: age 65+, transplant figure 9.27, prevalent transplant patients, 2000, unadjusted
Years
11.1+ (12.3)
10.0 to <11.1
9.7 to <10.0
9.0 to <9.7
below 9.0 (8.0)

55. Geographic variations in expected remaining lifetimes: age 65+, general Medicare figure 9.27, 2000, unadjusted
Years
15.1+ (15.6)
14.9 to <15.1
14.8 to <14.9
14.3 to <14.8
below 14.3 (14.0)